Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (1,988,322)	$ (2,948,566)
Adjustments to reconcile consolidated net loss to net cash flows from operating activities
Depreciation	1,564,144	1,003,534
Amortization	713,508	420,076
Loan cost amortization	53,617	60,588
Mandatorily redeemable preferred stock issuance cost and discount amortization	109,027	99,979
Convertible debenture issuance cost, discount and beneficial conversion feature amortization		1,718,487
Above (below) market lease amortization, net	(64,251)	3,618
Bad debt expense	12,946	3,196
Note payable forgiveness		(176,300)
Share-based compensation	233,100	149,981
Impairment of assets held for sale	175,671	0
Loss on impairment	36,670
Loss on extinguishment of debt	169,675
Changes in assets and liabilities
Rent and other receivables, net	169,139	67,645
Unbilled rent	(58,375)	(143,283)
Other assets	(199,905)	87,897
Accounts payable and accrued liabilities	647,128	647,341
Net cash flows from operating activities	1,573,772	994,193
CASH FLOWS FROM INVESTING ACTIVITIES
Investment property acquisitions	(10,279,714)	(10,205,385)
Capital expenditures	(492,704)	(72,852)
Net cash flows from investing activities	(10,772,418)	(10,278,237)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends and distributions paid	(729,790)	(12,000)
Repayment of line of credit, short term		(325,000)
Proceeds from mortgages payable, net	18,477,304	6,421,870
Repayment of mortgages payable	(11,407,226)	(266,270)
Proceeds from sale of convertible debentures, net of capitalized offering costs		1,305,000
Proceeds from sales of common stock, net of capitalized offering costs	1,538,887	10,853,605
Repurchases of common stock, including costs and fees	(286,543)
Net cash flows from financing activities	7,592,632	17,977,205
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(1,606,014)	8,693,161
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period	7,383,977	5,096,928
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period	$ 5,777,963	$ 13,790,089